Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler

Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Part A: RPL554;   Drug: Part B: RPL554;   Drug: Placebos Sponsors:   Verona Pharma plc;   Iqvia Pty Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials